[ad_1]
new york, August 18, 2022 /PRNewswire/ — WebMD Health Corp., an Internet brands company and leader in health information services for physicians, other healthcare professionals and consumers, announced today that it has acquired JIM.frThe leading medical news, information and education platform France.
The acquisition combines JIM.fr’s core competencies with Medscape, WebMD’s flagship brand for healthcare professionals (HCPs). Medscape and its network of affiliated platforms currently reach more than 5 million physicians worldwide with clinical news, health information and continuing medical education. With JIM.fr, Medscape strengthens its commitment to French and French-speaking HCPs.
“Both JIM.fr and Medscape have the trust and participation of hundreds of thousands of healthcare professionals France” he said Jeremy Schneider, Group General Manager, WebMD Global. “Medscape’s existing French edition, along with our strong country-specific content, is critical to our global commitment to French-speaking healthcare professionals. Through this transaction, we can leverage our combined assets to further strengthen Medscape’s offering to French and French-speaking professionals while providing clients with innovative solutions.”
As the premier medical news site at France, JIM.fr engages hundreds of thousands of doctors, nurses, pharmacists and other HCPs in more than 25 specialties. In addition to the latest medical news, clinical science and medical conference coverage updates, JIM.fr provides a versatile and interactive continuing education platform for the wider healthcare team.
“Today, JIM.fr has more than 350,000 French-speaking health care professionals registered on the site every day, offering a complete panorama of all specialized medical and professional news, including general medicine,” he said. Giles Harochefounder of JIM.fr “Beyond the scientific and journalistic rigor of its articles, JIM distinguishes itself from other medical media with its often humorous tone and original analysis of major issues that shake up the medical world. We are very happy to see the quality of our work. International medical news and care platform by Accredited by Medscape.
After the closing, JIM.fr will continue to operate as an independent subsidiary of Medscape while the companies seek to build and integrate products, platforms and services.
Terms of the purchase are not being disclosed.
About WebMD Health Corp.
WebMD Health Corporation, an Internet Brands company, is at the center of the digital health revolution that is transforming the healthcare experience for consumers, patients, healthcare professionals, employers, health plans and health systems. Through public and private online portals, mobile platforms and health-focused publications, WebMD offers original content and digital services that enable and improve decision making, support and encourage health actions, facilitate and simplify the healthcare journey, and improve patient care. .
The WebMD Health Network includes WebMD Health, Medscape, Jobson Healthcare Information, MediQuality, Frontline, Vitals Consumer Services, Aptus Health, Krames, PulsePoint, The Wellness Network, SanovaWorks, MNG Health, MedicineNet, eMedicineHealth, RxList, OnHealth, Medscape Education, and Other owned WebMD sites. WebMD®, Medscape®, CME Circle®, Medpulse®, eMedicine®, MedicineNet®, theheart.org® and RxList® are among the trademarks of WebMD Health Corporation or its subsidiaries.
About JIM.fr
Dr. Giles HarocheThen intern in “hospitals”. Paris(Hospital chain, Paris), based on “International Journal of Medicine“(Jim)
Thanks to the daily editorial collaboration of dozens of hospital and private professionals, JIM has set itself the goal of reporting in French “in real time” everything important that is being done and written in medicine worldwide. Scientific press, major congresses and professional news. His intensity and free and sometimes off-kilter tone made him a hit with his readers and advertisers. JIM is always ranked among the leading digital media sites in HCPs France.
SOURCE Medscape
[ad_2]
Source link
